Investment Rating - The report maintains a "Buy" rating for the company [2][5] Core Views - The company is experiencing stable revenue growth, with a profit turning point already evident [1] - Revenue forecasts for 2025-2027 have been adjusted downwards, while sales expense ratios have been increased, predicting net profits of 1.073 billion, 1.247 billion, and 1.395 billion yuan respectively for those years [2] Financial Performance Summary - **Revenue**: - 2023A: 24.531 billion yuan, 2024A: 26.497 billion yuan (YoY +8.0%), 2025E: 29.649 billion yuan (YoY +11.9%) [4] - **Net Profit**: - 2023A: 1.166 billion yuan, 2024A: 915 million yuan (YoY -21.6%), 2025E: 1.073 billion yuan (YoY +17.3%) [4] - **Earnings Per Share**: - 2023A: 1.02 yuan, 2024A: 0.80 yuan, 2025E: 0.94 yuan [4] - **Gross Margin**: - 2023A: 35.9%, 2024A: 34.3%, 2025E: 35.0% [4] - **Net Margin**: - 2023A: 4.8%, 2024A: 3.5%, 2025E: 3.6% [4] - **Return on Equity**: - 2023A: 17.9%, 2024A: 13.3%, 2025E: 14.3% [4] Business Expansion and Strategy - The company opened 907 new self-built stores and acquired 420 stores in 2024, with a total of 16,553 stores by the end of the year [9] - Retail business revenue reached 219.2 billion yuan in 2024, driven by the expansion of direct-operated stores and new openings [9] - The company is actively developing new retail business, achieving an 80.4% coverage rate for O2O delivery services by the end of 2024 [9]

| 纺织服饰 | 65.29 | -0.31 | -0.47 | | --- | --- | --- | --- | | 轻工制造 | 122.71 | -0.32 | -0.26 | | 美容护理 | 56.30 | -0.67 | -1.17 | | 商贸零售 | 209.95 | -0.72 | -0.34 | | 农林牧渔 | 251.04 | -2.30 | -0.91 | | 电子 | 2086.68 | -2.58 | -0.12 | | 银行 | 528.12 | -2.62 | -0.49 | 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） 截至6月3日，市场最新融资余额为17926.88亿元，较上个交易日环比增加34.52亿元，分行业统计，申万 所属一级行业有22个行业融资余额增加，计算机行业融资余额增加最多，较上一日增加6.74亿元；融资 余额增加居前的行业还有医药生物、家用电器、公用事业等，融资余额分别增加6.48亿元、5.85亿元、 5.03亿元；融资余额减少的行业有9个，银行、电子、农林牧渔等行业融资余额减少较多，分别减少2.62 亿元、2. ...

近5日机构合计调研302家公司，肇民科技、中微公司、华测检测等被多家机构扎堆调研。 证券时报·数据宝统计，近5个交易日（5月27日至6月3日）两市约302家公司被机构调研，调研机构类型 显示，证券公司共对272家公司进行调研，即90.07%的上市公司调研活动有证券公司参与；基金公司调 研232家，位列其后；阳光私募机构调研119家，排名第三。 机构调研榜单中，共有69家公司获20家以上机构扎堆调研。肇民科技最受关注，参与调研的机构达到 281家；中微公司被212家机构调研，榜单中排名第二；华测检测、拓荆科技等分别被187家、179家机构 调研。 机构调研次数来看，三友联众机构调研最为密集，共获机构4次调研。能辉科技、周大生等机构调研也 较为密集，均被机构调研3次。 数据宝统计，20家以上机构扎堆调研股中，近5日资金净流入的有24只，中科金财近5日净流入资金4.04 亿元，主力资金净流入最多；净流入资金较多的还有海大集团、北特科技等，净流入资金分别为2.46亿 元、1.27亿元。 市场表现上，机构扎堆调研股中，近5日上涨的有27只，涨幅居前的有华纳药厂、科兴制药、益方生物 等，涨幅为64.66%、53.29%、 ...

Group 1: Capital Market Overview - Global major asset classes are performing flat, reflecting the difficulty in finding certainty amid weak economic demand [2] - The pause in the tariff war has led to a temporary end to stock market valuation recovery, resulting in an overall calm market [2] - The automotive sector is experiencing adjustments due to inventory buildup and price competition, while sectors like environmental protection and biomedicine have seen some rebounds [2] Group 2: Economic Fundamentals - China's PMI data shows signs of stability but indicates a fragile recovery due to weak domestic demand and ongoing trade tensions [3] - The manufacturing PMI in China rose from 49.0% to 49.5%, while the non-manufacturing business activity index decreased slightly to 50.3% [3] - In the U.S., the manufacturing PMI recorded 48.5%, indicating a contraction for the third consecutive month, with most demand and output indicators showing a downward trend [4][5] Group 3: External Shocks - The U.S. has increased steel import tariffs to 50%, which is seen as a step to reduce reliance on China, exacerbating trade tensions [7] - The ongoing conflict in Ukraine is expected to prolong the situation and may escalate, impacting global stability and investor sentiment [8] - The emergence of stablecoins is viewed as a potential solution to debt issues, as they can enhance bond purchasing power and may lead to inflationary pressures in the long term [9] Group 4: Strategic Recommendations - In the face of increasing uncertainty, a prudent strategy is to remain inactive and conserve resources for future opportunities [10]

6月3日沪指上涨0.43%，市场两融余额为18044.88亿元，较前一交易日增加35.42亿元。 证券时报·数据宝统计显示，截至6月3日，沪市两融余额9147.66亿元，较前一交易日增加15.17亿元；深 市两融余额8843.29亿元，较前一交易日增加20.26亿元；北交所两融余额53.94亿元，较前一交易日减少 224.57万元；深沪北两融余额合计18044.88亿元，较前一交易日增加35.42亿元。 | | 份 | | | | | | --- | --- | --- | --- | --- | --- | | 301096 | 百诚医 | 21061.04 | 24.85 | 7.06 | 医药生物 | | | 药 | | | | | | 600350 | 山东高 | 3323.58 | 24.74 | -2.10 | 交通运输 | | | 速 | | | | | | 001326 | 联域股 | 10054.93 | 24.59 | 0.89 | 家用电器 | | | 份 | | | | | | 833943 | 优机股 | 1306.50 | 24.30 | 8.14 | 机械设备 | | | 份 | ...

2025 年 06 月 03 日 投资策略 估值与盈利周观察——5 月第 4 期：小微盘占优 ◼ 上证综合指数走势（近三年） (20%) (12%) (4%) 4% 12% 20% 24/6/3 24/8/14 24/10/25 25/1/5 25/3/18 25/5/29 证券分析师：张冬冬 大类行业估值：原材料、设备制造、工业服务、交通运输、消费、科 技历史估值皆处于 50%以下，金融地产估值高于 50%历史分位。 一级行业估值：各行业估值分化，非银金融、有色金属、通信、电子、 农林牧渔、家电估值处于近一年低位。 电话： E-MAIL：zhangdd@tpyzq.com 分析师登记编号：S1190522040001 证券分析师：吴步升 电话： E-MAIL：wubs@tpyzq.com 分析师登记编号：S1190524110002 市场估值分化，小微盘占优。上周宽基指数估值分化，微盘股表现最 优，创业板指表现最弱。从 PE、PB 偏离度的角度看，食品饮料、农林牧 渔、公用事业等行业估值较为便宜。向前看，本周市场 ERP 与前一周持 平，处于一倍标准差附近。 市场表现：微盘股、国证 2000、稳定表现最好； ...

证券研究报告 信用业务周报 近期内外风险扰动或带来哪些影响？ 2025年6月3日 中泰证券研究所 分析师：徐驰 执业证书编号：S0740519080003 分析师：张文宇 执业证书编号：S0740520120003 请务必阅读正文之后的信息披露和重要声明 【市场回顾】 图表：市场表现回顾 数据来源：Wind，中泰证券研究所 2 【市场观察】内外扰动交织下市场或如何演绎？ 3 • 一、内外扰动交织下市场或如何演绎？ • 当前市场正处于内外政策变量交织扰动的关键节点，国内"十五五"规划奠定基调、公募基金改革或重 塑市场，国外欧美关税博弈加剧、美国国内政策不确定性增强等政策扰动均将对市场产生复杂影响。 • 国内宏观方面，高质量发展的核心框架或不断强化，科技创新、制造业发展或仍是下一个五年计划的 发展重心。近期总书记在河南考察时的表态再次确认了国家对制造业和科技创新的高度重视，明确了 未来五年我国将持续把科技创新与制造业高质量发展作为战略核心。 • 国内资本市场政策方面，公募改革影响或超出市场预期，重塑行业生态。《推动公募基金高质量发展 行动方案》显著增强了基金业绩比较基准的约束力，对市场风格和资产配置产生深远影响， ...

Core Insights - The Shanghai Composite Index rose by 0.43% on June 3, with 20 out of 28 sectors experiencing gains, particularly in the beauty care and textile sectors, which increased by 3.86% and 2.53% respectively [1] - The pharmaceutical and biotechnology sector saw a rise of 1.78%, with a net inflow of 9.17 billion yuan in capital [1] - Among the 475 stocks in the pharmaceutical sector, 416 stocks increased, with 14 hitting the daily limit up, while 54 stocks declined [1] Capital Flow Analysis - The pharmaceutical sector had 221 stocks with net capital inflows, with 6 stocks receiving over 100 million yuan in net inflows. Leading the inflow was Huahai Pharmaceutical with 266.1 million yuan, followed by Qianhong Pharmaceutical and Hehua Co., which received 201.5 million yuan and 168 million yuan respectively [1] - The outflow list included 6 stocks with net outflows exceeding 50 million yuan, with the highest outflows from Ruizhi Pharmaceutical, Hengrui Medicine, and Mindray Medical, which saw outflows of 237 million yuan, 110 million yuan, and 109 million yuan respectively [2] Pharmaceutical Sector Performance - The top gainers in the pharmaceutical sector included: - Huahai Pharmaceutical: +7.63%, turnover rate 7.71%, capital flow 266.1 million yuan - Qianhong Pharmaceutical: +10.05%, turnover rate 17.02%, capital flow 201.5 million yuan - Hehua Co.: +9.95%, turnover rate 18.47%, capital flow 167.7 million yuan [1] - The top decliners included: - Ruizhi Pharmaceutical: -13.15%, turnover rate 34.15%, capital flow -236.7 million yuan - Hengrui Medicine: -0.26%, turnover rate 0.68%, capital flow -109.7 million yuan - Mindray Medical: -3.02%, turnover rate 0.58%, capital flow -108.9 million yuan [2] ETF Insights - The Hang Seng Medical ETF, which tracks the Hang Seng Hong Kong-listed biotechnology index, experienced a 5-day increase of 3.59% with a net inflow of 9.86 million yuan [5]

今日各行业主力资金流向一览 | 行业名称 | 成交量 | 成交量 较昨日 | 换手率 | 涨跌幅 | 今日 | | --- | --- | --- | --- | --- | --- | | | （亿股） | 增减 | （%） | （%） | 主力资金 净流入（亿元） | | | | （%） | | | | | 有色金属 | 30.84 | 30.12 | 1.42 | 1.40 | 14.01 | | 医药生物 | 77.75 | 7.98 | 2.87 | 1.78 | 9.17 | | 银行 | 50.35 | 32.17 | 0.38 | 1.98 | 6.27 | | 非银金融 | 31.67 | 19.42 | 0.77 | 0.97 | 5.61 | | 纺织服饰 | 17.79 | 8.03 | 2.55 | 2.53 | 5.25 | | 交通运输 | 36.70 | -6.67 | 0.88 | 0.25 | 4.75 | | 传媒 | 44.34 | 23.96 | 3.05 | 1.37 | 4.64 | | 社会服务 | 11.18 | 25.25 | 2.45 | 1.37 | 3 ...

（原标题：科创板平均股价29.68元，10股股价超200元） 以最新收盘价计算，科创板平均股价为29.68元，其中股价超100元的有36只，股价最高的是寒武纪。 证券时报•数据宝统计显示，科创板股今日上涨的有393只，下跌的有184只，以收盘价为基准测算，科创板平均股价为29.68元，其中，收盘价超 过100元的有36只，股价在50元至100元之间的有100只，股价在30元至50元的有150只。 科创板股中，收盘价最高的是寒武纪，今日报收595.86元，下跌1.29%，其次是恒玄科技、惠泰医疗等，最新收盘价分别为396.03元、392.12元。 科创板百元股中，今日平均上涨1.30%，具体来看，今日上涨的有25只，涨幅居前的有热景生物、泽璟制药、思瑞浦等。下跌的有10只，跌幅居 前的有源杰科技、经纬恒润、百利天恒等。 向前追溯发现，科创板百元股最新收盘价相对发行价平均溢价311.11%，溢价幅度居前的有百利天恒、安集科技、寒武纪等，溢价幅度分别为 1084.41%、984.18%、825.39%。 以申万一级行业分类，科创板百元股较为集中的行业有电子、医药生物、计算机等，分别有16只、8只、6只股票上榜。 资 ...